Drug Type Small molecule drug |
Synonyms ZSTK 474, ZSTK474 |
Target |
Action- |
Mechanism PIK3R3 inhibitors(phosphoinositide-3-kinase regulatory subunit 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H21F2N7O2 |
InChIKeyHGVNLRPZOWWDKD-UHFFFAOYSA-N |
CAS Registry475110-96-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 01 Jan 2011 | |
Wilms Tumor | Preclinical | China | 28 Oct 2024 | |
Glioblastoma | Preclinical | New Zealand | 27 Sep 2011 | |
Rheumatoid Arthritis | Preclinical | Japan | 11 Jun 2008 | |
Rheumatoid Arthritis | Preclinical | Japan | 11 Jun 2008 | |
Rheumatoid Arthritis | Preclinical | Japan | 11 Jun 2008 |